Clinical trial
Erythropoietin (EPO) and Ischemia-reperfusion After Kidney Transplantation
NCT00425698 · Hannover Medical School, Other · Completed
Key facts
| NCT number | NCT00425698 |
|---|---|
| Title | Erythropoietin (EPO) and Ischemia-reperfusion After Kidney Transplantation |
| Official title | Effect of Erythropoietin on Renal Function After Kidney Transplantation |
| Lead sponsor | Hannover Medical School, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Transplantation |
| Intervention type | Drug |
| Interventions | Recombinant erythropoietin alpha (rHuEPO alpha), Placebo |
| Enrollment | 88 |
| Start date | Feb 1, 2007 |
| Primary completion | May 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Jan 23, 2007 |
| Last update posted | Sep 28, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: